In this issue:
Adalimumab-fkjp biosimilar in chronic plaque psoriasis
Roflumilast foam for psoriasis of the scalp and body
Adalimumab + methotrexate for psoriasis
Low-grade systemic inflammation and risk of psoriasis
Hormone therapy and risk of psoriasis
Impact of psoriasis on sleep quality
Risk of malignancy with long-term TNF inhibitors
Psoriatic arthritis screening
Nail psoriasis severity index scored by artificial intelligence
Apremilast in oncological patients with plaque psoriasis
Please login below to download this issue (PDF)